Entera Bio Ltd. (ENTX) vs TuHURA Biosciences, Inc. (HURA)
A side-by-side comparison of Entera Bio Ltd. and TuHURA Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENTX
Entera Bio Ltd.
$2.61HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
HURA
TuHURA Biosciences, Inc.
$1.91HealthcareDelayed quote: Oct 6, 2026, 11:58 AM EDT
Total return — ENTX vs HURA
growth of $100 · dividends reinvested · last 8yENTX -58.3% (-10.4%/yr)HURA -99.4% (-47.6%/yr)ENTX compounded faster over this window
Log scale — wide-divergence pair
ENTX HURA
ENTX vs HURA: by the numbers
- •ENTX is the larger company ($128M vs $122M market cap).
- •Both run net losses; HURA's is the smaller (0.00% vs -27235.71% net margin).
Metrics side by side
Valuation
| Metric | ENTX | HURA |
|---|---|---|
| P/B ratio | 17.67 | 6.68 |
Profitability
| Metric | ENTX | HURA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | -27450.00% | 0.00% |
| Net margin | -27235.71% | 0.00% |
| ROE | -234.42% | -165.57% |
| ROIC | -82.87% | -137.40% |
Growth (annualized)
| Metric | ENTX | HURA |
|---|---|---|
| Total return CAGR (5Y) | -10.57% | -45.49% |
Frequently asked
- How have ENTX and HURA total returns compared?
- Over the past 5 years, ENTX delivered -10.57% and HURA delivered -45.49% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.